Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Novavax

Clinical trials sponsored by Novavax, explained in plain language.

Novavax NVAX NASDAQ

A vaccine company known for its COVID-19 vaccine and other infectious disease vaccines.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 4

New novavax JN.1 vaccine trial aims to protect adults 50-64 from COVID

⭐️ VACCINE ⭐️ Ongoing

This study tests a single dose of an updated Novavax COVID-19 vaccine designed to target the JN.1 variant. About 6,500 healthy adults aged 50 to under 65 who are not at high risk for severe COVID will receive either the vaccine or a placebo. Researchers will track how well the va…

Phase: PHASE4 • Sponsor: Novavax • Aim: ⭐️ VACCINE ⭐️

Last updated Jun 27, 2026 12:30 UTC